Home

Headache

Alzheimer's Disease

Read time: 4 min

Congress highlights

Biofluid-based biomarkers – realizing their potential in Alzheimer’s disease

Henrik Zetterberg, University of Gothenberg, Sweden and University College London, UK, during the...

The elements of patient centric treatment that make it different from standard practice

Dr Iria Grande sat down with us at ECNP 2021 to introduce herself and discuss patient centric...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Targeting tau – homing-in on effective therapies in Alzheimer’s disease

Several new and highly promising therapeutics for the management and possible prevention of...

Read time: 3 min

Congress highlights

New 2021 guidelines for the treatment of schizophrenia are now available in Japan

The new evidence-based guidelines for the pharmacological therapy of schizophrenia from the...

Functionality goals in schizophrenia: The therapeutic alliance and importance of noting the side effect profile of antipsychotics

At ECNP 2021, Professor Andrea Fagiolini discussed with us how, for a person with schizophrenia,...

Read time: 2 min

Congress highlights

Focus on general migraine burden and during pregnancy in Arab countries

During a regional symposium of the Pan-Arab Union of Neurological Societies (PAUNS) held at #...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Diagnosing neuropsychiatric symptoms in Alzheimer’s disease

Neuropsychiatric symptoms occur commonly in patients with neurodegenerative disorders. Such...

Read time: 2 min

Congress highlights

New insights from posters at IHC2021 — migraine and body mass index and the everyday burden of migraine

What is the relationship between high body mass index and migraine? and What is the real-world...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country